Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$209.01 - $232.56 $3.62 Million - $4.03 Million
17,323 Added 141.33%
29,580 $6.46 Million
Q4 2023

Feb 01, 2024

BUY
$197.69 - $227.29 $2.42 Million - $2.79 Million
12,257 New
12,257 $2.79 Million
Q1 2023

Jun 27, 2023

BUY
$213.32 - $257.83 $4.39 Million - $5.3 Million
20,570 New
20,570 $4.72 Million
Q3 2022

Nov 03, 2022

BUY
$204.81 - $262.19 $1.04 Million - $1.33 Million
5,090 New
5,090 $1.04 Million
Q2 2022

Aug 08, 2022

SELL
$213.86 - $277.87 $767,757 - $997,553
-3,590 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$259.82 - $298.18 $932,753 - $1.07 Million
3,590 New
3,590 $947,000
Q4 2021

Feb 02, 2022

SELL
$271.6 - $314.21 $5.48 Million - $6.34 Million
-20,185 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$274.82 - $308.34 $5.55 Million - $6.22 Million
20,185 New
20,185 $5.68 Million
Q1 2020

May 06, 2020

SELL
$104.32 - $195.28 $3.75 Million - $7.02 Million
-35,944 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$163.48 - $173.61 $233,122 - $247,567
-1,426 Reduced 3.82%
35,944 $6.08 Million
Q3 2019

Nov 08, 2019

BUY
$159.77 - $178.1 $5.97 Million - $6.66 Million
37,370 New
37,370 $6.28 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.